PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biotherapies, AABB, Bethesda, Maryland, USA.\', \'Doctor of Public Health Leadership Department, University of Illinois at Chicago, Chicago, Illinois, USA.\', \'X-CellSystem, Inc., Seattle, Washington, USA.\', \'Department of Hematology, Sultan Qaboos University Hospital, Muscat, Oman.\', \'Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.\', \'Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'International Development of Transfusion Medicine, University of Groningen, Zuidhorn, The Netherlands.\', \'Vanderbilt University Medical Center, Nashville, Tennessee, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/trf.16798
?:doi
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 35023585
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
?:title
  • COVID-19 and the impact on blood availability and transfusion practices in low- and middle-income countries.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all